At the T.H. Chan School of Public Health, which relies heavily on federal support, a crisis response is underway and a ...

Shift Bioscience, a Cambridge-based biotech company using an AI powered virtual cell to fight age-driven diseases, has ...

The average American can expect to live about 77 years, according to the Centers for Disease Control and Prevention. Retro ...

While Pacific Biosciences' earnings were beat, shrinking sales, high debt, and poor macro environment do not inspire ...

Shift Bioscience (Shift), a biotech company using an AI-powered virtual cell to fight age-driven diseases, appointed Lord ...

New research published in BioScience reveals that climate change is rapidly emerging as a third major threat to Earth's wild ...

Shift Bioscience (Shift), a biotech company using an AI powered virtual cell to fight age-driven diseases, today announced the appointments of Lord David Prior as Chair of the Board and Sir Tony ...

A new frontier into advancing treatments for children and adults with bone marrow failure, leukemia and other blood disorders ...

A 75-person team at Seattle's Allen Institute is embarking on a 10-year project called CellScapes to devise a mathematical ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's ...